Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma

British Journal of Haematology

Volumn 109, Issue 1, 2000, Pages 39-45

  Zheng, Chengyun ^a   Huang, DeRen ^a   Bergenbrant, Susanne ^a   Sundblad, Anne ^a   Österborg, Anders ^a   Björkholm, Magnus ^a   Holm, GÖRAN ^a   Yi, Qing ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Gene; IL 1Ra; Multiple myeloma; Polymorphism; Proinflammatory cytokines

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TANDEM REPEAT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-6; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHIES, BENIGN; MULTIPLE MYELOMA; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SIALOGLYCOPROTEINS;

EID: 0034037019     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01963.x     Document Type: Article

References (54)

1. Anderson, K.C. & Lust, J.A. (1999) Role of cytokines in multiple myeloma. Seminars in Haematology, 36, 14-20.
2. Bakkus, M.H., Heirman, C., Van Riet, I., Van Camp, B. & Thielemans, K. (1992) Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood, 80, 2326-2335.
3. Barlogie, B. & Alexanian, R. (1989) Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma. Cancer Research, 49, 7172-7175.
4. Bataille, R. (1997) New insight in the clinical biology of multiple myeloma. Seminars in Hematology, 34 (Suppl. 1), 23-28.
5. Bertolini, D.R., Nedwin, G.K., Bringman, T.S., Smith, D.D. & Mundy, G.R. (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature, 319, 516-518.
6. Bloque, G., Crusius, J.B., Koutroubakis, I., Bouma, G., Kostense, P.J., Meuwissen, S.G. & Pena, A.S. (1995) Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clinical Experimental Immunology, 102, 379-383.
7. Bouma, G., Crusius, J.B.A., Pool, M.O., Kolkman, J.J., Von Blomber, B.M.E., Kostense, P.J., Giphart, M.J., Schreuder, G.M.T., Meuwissen, S.G.M. & Pena, A.S. (1996) Secretion of tumor necrosis factor α and lymphotoxin α in relation to polymorphism in the TNF genes and HLA-Dr alleles. Relevance for inflammatory bowel disease. Scandinavian Journal of Immunology, 43, 456-563.
8. Brieva, J.A., Martin, R.A., Martinez-Maza, O., Kagan, J., Merrill, J., Saxon, A., Van Damme, J. & Stevens, R.H. (1990) Interleukin 6 is essential for antibody secretion by human in vivo antigen-induced lymphoblastoid B cells. Cellular Immunology, 130, 303-310.
9. Brown, L.M., Linet, M.S., Greenberg, R.S., Silverman, D.T., Hayes, R.B., Swanson, G.M., Schwartz, A.G., Schoenberg, J.B., Pottern, L.M. & Fraumeni, Jr. J.F. (1999) Multiple myeloma and family history of cancer among blacks and whites in the US. Cancer, 85, 2385-2390.
10. Carter, A., Merchav, S., Silvian-Draxler, I. & Tatarsky, I. (1990) The role of interleukin-1 and tumor necrosis factor-α in human multiple myeloma. British Journal of Haematology, 74, 424-431.
11. Chauhan. D., Kharbanda, S., Ogata, A., Urashima, M., Teoh, G., Robertson, M., Kufe, D.W. & Anderson, K.C. (1997) Interleukin-6 inhibits induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood, 89, 227-234.
12. Chiplunkar, S., Langhorne, J. & Kaufmann, S.H. (1986) Stimulation of B cell growth and differentiation by murine recombinant interleukin 1. Journal of Immunology, 137, 3748-3752.
13. Costes, V., Portier, M., Lu, Z.Y., Rossi, J.F., Bataille, R. & Klein, B. (1998) Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production. British Journal of Haematology, 101, 1152-1160.
14. Danis, V.A., Millington, M., Hyland, V.J. & Gennan, D. (1995) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism Clinical Experimental Immunology, 99, 303-310.
15. Demeter, J., Messer, G., Ramisch, S., Mee, J.B., Giovine, F.S., Schmid, M., Herrmann, F. & Porzsolt, F. (1996) Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokines and Molecular Therapy, 2, 239-242.
16. Dinarello, C.A. (1996) Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
17. Donovan, K.A., Lacy, M.Q., Kline, M.P., Ahmann, G.J., Heimbach, J.K., Kyle, R.A. & Lust, J.A. (1998) Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma. Leukemia, 12, 593-600.
18. Durie, B.G. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
19. Filella, X., Blade, J., Guillermo, Molina, R., Rowman, C. & Ballesta, A.M. (1996) Cytokine (IL-6, TNF-alpha, IL-1 alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma. Cancer Detection and Prevention, 20, 52-56.
20. Fishman. D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S. & Woo, P. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102, 1369-1376.
21. Gowen, M., Wood, D.D., Ihrie, E.J., McGuire, M.K. & Russell, R.G. (1983) An interleukin 1 like factor stimulates bone resorption in vitro. Nature, 306, 378-380.
22. Grosbois, B., Jego, P., Attal, M., Payen, C., Rapp, M.J., Fuzibet, T.G., Maigre, M. & Bataille, R. (1999) Familial multiple myeloma: report of fifteen families. British Journal of Haematology, 105, 768-770.
23. Hacker, U.T., Bidlingmaier, C., Gomolka, M., Keler, E., Eigler, A., Hartmann, G., Folwaczny, C., Fricke, H., Albert, E., Loeschke, K. & Endres, S. (1998) Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) 1 beta and IL-1 receptor antagonist gene polymorphisms. European Journal of Clinical Investigation, 28, 214-219.
24. Hallek, M., Bergsagel, P.L. & Anderson, K.C. (1998) Multiple myeloma: increasing evidence for a multistep transformation process. Blood, 91, 3-21.
25. Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H. & Epstein, J. (1994) Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood, 84, 3063-3070.
26. Hirsch, E., Irikura, V.M., Paul, S.M. & Hirsh, D. (1996) Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proceedings of the National Academy of Sciences of the United States of America, 93, 11008-11013.
27. Hurme, M. & Santtila, S. (1998) IL-1 receptor antagonist (IL-1 Ra) plasma levels are co-ordinately regulated by both IL1 Ra and IL-1 beta genes. European Journal of Immunology, 28, 2598-2602.
28. Jandl, R.C., Flanagan, R.G. & Schur, P.H. (1988) Interleukin-1 stimulation of human B-lymphoblast differentiation. Clinical Immunology and Immunopathology, 46, 115-121.
29. Jourdan, M., Tarte, K., Legouffe, E., Broehier, J., Rossi, J. & Klein, B. (1999) Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. European Journal of Cytokine Networks, 10, 65-70.
30. Kiss, T.L., Lipton, J.H., Bergsagel, D.E., Meharchand, J.M., Jamal, N., Minden, M.D. & Messner, H.A. (1994) Determination of IL6, IL1, and IL4 in the plasma of patients with multiple myeloma. Leukemia and Lymphoma, 14, 335-340.
31. Klein, B. (1995) Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma. Seminars in Hematology, 32, 4-19.
32. Kyle, R.A. (1993) 'Benign' monoclonal gammopathy - after 20-35 years of follow-up. Mayo Clinic Proceedings, 68, 26-36.
33. Kyrstsonis, M.C., Dedoussis, G., Baxevanis, C., Stamatelou, M. & Maniatis, A. (1996) Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM). British Journal of Haematology, 92, 420-422.
34. Lacy, M.Q., Donovan, K.A., Heimbach, J.K., Ahmann, G.J. & Lust, J.A. (1999) Comparison of interleukin-1β expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma. Blood, 93, 300-305.
35. Lichtenstein, A., Tu, Y., Fady, C., Vescio, R. & Berenson, J. (1995) lnterleukin-6 inhibits apoptosis of malignant plasma cells. Cellular Immunology, 162, 248-255.
36. Louis, E., Franchimont, D., Piron, A., Gevaert, Y., Schaaf-Lafontaine, N., Roland, S., Mahieu, P., Malaise, M., De Groote, D., Louis, R. & Belaiche, J. (1998) Tumor necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clinical Experimental Immunology, 113, 401-406.
37. Lust, J.A. (1994) Role of cytokines in the pathogenesis of monoclonal gammopathies. Mayo Clinic Proceedings, 69, 691-697.
38. Mansfield, J.C., Holden, H., Tarlow, J.K., Di Giovine, F.S., Mcdowell, T.L., Wilson, A.G. & Holdsworth, C.D. (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cylokine interleukin-1 receptor antagonist. Gastroenterology, 106, 637-642.
39. McCrea, A.P. & Morris, T.C. (1986) Concurrent familial myeloma in Northern Ireland. Cancer, 58, 394-396.
40. Mellstedt, H., Bjorkholm, M. & Holm, G. (1977) Intermittent melphalan and prednisolone therapy in plasma cell myeloma. Acta Medica Scandinavica, 202, 5-9.
41. Nicklin, M.J.H., Weith, A. & Duff, G.W. (1994) A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics, 19, 382-384.
42. Olomolaiye, O., Wood, N.A. & Bidwell, J.L. (1998) A novel NlaIII polymorphism in the human IL-6 promoter. European Journal of Immunogenetics, 25, 267.
43. Pettersson, D., Mellstedt, H., Holm, G. & Bjorkholm, M. (1981) Monoclonal blood lymphocytes in benign monoclonal gammopathy and multiple myeloma in relation to clinical stage. Scandinavian Journal of Haematology, 27, 287-293.
44. Pociot, F., Molvig, J., Wogensen, L., Worsaae, H. & Nerup, J. (1992) A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. European Journal of Clinical Investigations, 22, 396-402.
45. Rieckmann, P., D'Alessandro, F., Nordan, R.P., Fauci, A.S. & Kehrl, J.H. (1991) 1L-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. Journal of Immunology, 46, 3462-3468.
46. Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E. & Mantovani, A. (1989) IL-1 stimulates IL-6 production in endothelial cells. Journal of Immunology, 142, 549-553.
47. Tarlow, J.A., Blakemore, A.I.F., Lennard, A., Solari, R., Hughes, H.N., Steinkasserer, A. & Duff, G.W. (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 bp tandem repeat. Human Genetics, 91, 403-404.
48. Tatsuta, T., Cheng, J. & Mountz, J.D. (1996) Intracellular IL-1beta is an inhibitor of Fas-mediated apoptosis. Journal of Immunology, 157, 3949-3957.
49. Torcia, M., Lucibello, M., Edouard, V., Silvia, F., Miliani, A., Guidi, G., Spada, O., Dower, S.K., Sims, J.E., Shaw, A.R., Dinarello, C.A., Garaci, E. & Cozzolino, F. (1996) Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors. Experimental Hematology, 24, 868-874.
50. Tzilianos, M., Mitsouli-Metnikof, X., Tsoukali. E., Klonou, E., Papathanasiou, M., Giannakaki, A., Sampani, M., Duvogiannis, C. & Nikiforakis, M. (1999) Familial myeloma. Haematologica, 84, 28.
51. Warzocha, K., Ribeiro. P., Bienvenu, J., Roy, P., Charol, C., Rigal, D., Coiffier, B. & Salles, G. (1998) Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood, 91, 3574-3581.
52. Wierzbowska, A., Urbanska-Rys, H. & Robak, T. (1999) Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma. British Journal of Haematology, 105, 412-419.
53. Wilson, A.G., di Giovine, F.S., Blakemore, A.I. & Duff, G.W. (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Human Molecular Genetics, 1, 353.
54. Wilson, A.G., Symons, J.A., Mcdowell, T.L., Mcdevitt, H.O. & Duff, G.W. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcription activation. Proceedings of the National Academy of Sciences of the United States of America, 94, 3195-3199.